Betta Pharmaceuticals Co., Ltd. (SHE:300558)
41.62
-0.93 (-2.19%)
Nov 20, 2026, 3:04 PM CST
Betta Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Betta Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of ¥58.14. The average 1-year stock price forecast is 39.69% higher than the current stock price, while the lowest is ¥37.23 (-10.55%) and the highest is ¥79.05 (+89.93%).
Price Target: ¥58.14 (+39.69%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Betta Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 5 | 3 | 2 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
3.94B
from 3.61B
Increased by 9.12%
Revenue Next Year
4.50B
from 3.94B
Increased by 14.33%
EPS This Year
3.14
EPS Next Year
n/a
from 3.14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.